US$ 22.15
innoviva glp-1 receptor agonist weight management diabetes treatments Added Value to Agonist: Intermittent Fasting and Lifestyle Modification to Improve Therapeutic Effects and Outcomes GLP-1 RA education
Description
performed molecular docking
Peptides 1994

Regular monitoring and necessary adjustments to diet or treatment can help maintain balance

Multiple randomised, placebo-controlled trials have tested GLP-1 drugs as add-on therapy to insulin in people with T1D, and the picture that emerges is consistent, if modest: meaningful weight loss, real reductions in daily insulin needs, and improvements in CGM time in range

R., Cho, H

J Exp Biol
